431 related articles for article (PubMed ID: 20540591)
1. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.
Langer RD
Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591
[TBL] [Abstract][Full Text] [Related]
2. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
4. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
5. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
6. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
7. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
[TBL] [Abstract][Full Text] [Related]
9. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
10. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
Salpeter S
Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
[TBL] [Abstract][Full Text] [Related]
12. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
13. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
14. Current recommendations: what is the clinician to do?
Manson JE
Fertil Steril; 2014 Apr; 101(4):916-21. PubMed ID: 24680650
[TBL] [Abstract][Full Text] [Related]
15. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
[TBL] [Abstract][Full Text] [Related]
16. Estrogen with and without progestin: benefits and risks of short-term use.
LaCroix AZ
Am J Med; 2005 Dec; 118 Suppl 12B():79-87. PubMed ID: 16414331
[TBL] [Abstract][Full Text] [Related]
17. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
18. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
Hillman JJ; Zuckerman IH; Lee E
J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
[TBL] [Abstract][Full Text] [Related]
19. Risks of hormone therapy in the 50-59 year age group.
van de Weijer PH
Maturitas; 2008 May; 60(1):59-64. PubMed ID: 18556157
[TBL] [Abstract][Full Text] [Related]
20. The evidence base for HRT: what can we believe?
Langer RD
Climacteric; 2017 Apr; 20(2):91-96. PubMed ID: 28281363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
